| 貨號(hào) | 規(guī)格 | 價(jià)格 | 上海 | 北京 | 武漢 | 南京 | 購買數(shù)量 |
|---|---|---|---|---|---|---|---|
S81250-10mg |
≥98% | ￥700.00 | 8 | - | - | - |
|
S81250-25mg |
≥98% | ￥1400.00 | 7 | - | - | - |
|
S81250-50mg |
≥98% | ￥2300.00 | 4 | - | - | - |
|
S81250-100mg |
≥98% | ￥3700.00 | 2 | - | - | - |
|
Cefoselis is a widely used beta-lactam antibiotic.
| 產(chǎn)品描述： | Cefoselis is a widely used beta-lactam antibiotic. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點(diǎn)： | Antibacterial;Antibiotic;Antibacterial;?Antibiotic | ||||||||||||||||||||
| 體內(nèi)研究： | Cefoselis elicits a massive elevation of extracellular glutamate concentration in normal rats. Cefoselis (50 mg/animal)-induced convulsions are prevented by pretreatment with 5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), diazepam and phenobarbital (ED(50) values (mg/kg) of 0.78, 1.59 and 33.0, respectively), but not by carbamazepine or phenytoin. | ||||||||||||||||||||
| 參考文獻(xiàn)： | 1. Yamazaki S, et al. Pharmacol Biochem Behav, 2002, 74(1), 53-59. 2. Ohtaki K, et al. J Neural Transm, 2004, 111(12), 1523-1535. 3. Yamada K, et al. J Infect Chemother, 2012, 18(4), 472-478. 4. Sugimoto M, et al. Br J Pharmacol, 2002, 135(2), 427-432. 5. Giamarellos-Bourboulis EJ, et al. Diagn Microbiol Infect Dis, 2000, 36(3), 185-191. | ||||||||||||||||||||
| 溶解性： | Soluble in DMSO | ||||||||||||||||||||
| 保存條件： | -20℃;充氬 | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網(wǎng)安備 31011702002021號(hào)
危險(xiǎn)品化學(xué)品經(jīng)營許可證（不帶存儲(chǔ)）
營業(yè)執(zhí)照(三證合一)
北京